Ceftolozane-tazobactam for the Treatment of Respiratory Infections Due to Extensively Drug-resistant Pseudomonas Aeruginosa Among Critically Ill Patients: a Retrospective Study.
Condition(s):Ventilator Associated Pneumonia; Antibiotic Resistant InfectionLast Updated:April 20, 2020Unknown status